UNIVERSAL HEALTH SERVICES INC UHS

NYSE Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$194.28
$138.06
$246.33
Market cap
$12.52B
P/E (GAAP, TTM)
8.14
P/E (operating)
8.20
Dividend yield
0.4%
Revenue growth YoY
5.3%
EPS growth YoY
-10.9%
ROIC
12.9%
Piotroski F-score
7

Three ways to read the P/E

P/E (GAAP, TTM)
8.14

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
8.41

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
8.20

After-tax operating income only: the core business.

P/E (excl. gains)
8.84

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) 8.3% 9.6%-1.4 pts ——
EPS growth YoY (qtr) 10.1% 17.7%-7.6 pts ——
Revenue growth (TTM) 10.0% 10.4%-0.4 pts ——
EPS growth (TTM) 29.2% 34.6%-5.4 pts ——
P/E (GAAP, TTM) 7.12 6.21+0.90 ——
P/E (operating) 7.35 6.28+1.08 ——
P/E (excl. gains) 7.93 6.76+1.16 ——
P/B 1.54 1.32+0.23 ——
ROIC 12.9% 12.9%0.0 pts ——
Net margin 8.6% 8.6%0.0 pts ——
Dividend yield 0.5% 0.5%-0.1 pts ——
EPS (TTM) 24.50 23.95+2.3% ——
Price $174.32 $148.74+17.2% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $4.73B 2.1% 5.3% 5.22 -12.7% -10.9% 6.5%
Jun 30, 2026 $4.64B 3.2% 8.3% 5.98 5.8% 10.1% 7.7%
Mar 31, 2026 $4.50B 0.2% 9.6% 5.65 -19.4% 17.7% 7.8%
Dec 31, 2025 * $4.49B -0.2% 9.1% 7.01 19.6% 41.9% 9.9%
Sep 30, 2025 $4.50B 4.9% 13.4% 5.86 7.9% 54.2% 8.3%
Jun 30, 2025 $4.28B 4.5% 9.6% 5.43 13.1% 27.5% 8.2%
Mar 31, 2025 $4.10B -0.3% 6.7% 4.80 -2.8% 25.7% 7.7%
Dec 31, 2024 * $4.11B 3.8% 11.1% 4.94 30.0% 57.8% 8.1%
Sep 30, 2024 $3.96B 1.4% 11.2% 3.80 -10.8% 58.3% 6.5%
Jun 30, 2024 $3.91B 1.7% 10.1% 4.26 11.5% 76.0% 7.4%
Mar 31, 2024 $3.84B 3.8% 10.8% 3.82 22.0% 67.5% 6.8%
Dec 31, 2023 * $3.70B 4.0% 7.4% 3.13 30.4% 29.3% 5.8%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 13, 2026 Date of the latest closing price used.
Price $194.28 Latest closing price.
Market cap $12.52B Price × shares outstanding.
Enterprise value $17.14B Market cap + debt − cash: the price of the whole business.
Shares 64.46M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 8.41 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) 8.14 Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 8.20 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 8.21 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 8.84 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG 0.23 P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) 0.61 TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 11.9% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) 12.3% TTM EPS ÷ price.
P/B 1.72 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 0.72 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 0.68 Market cap ÷ revenue of the last four quarters.
P/FCF 14.75 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 6.56 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT 8.59 Enterprise value ÷ operating income.
EV/Sales 0.99 Enterprise value ÷ revenue.
Book value / share 112.87 Shareholders' equity ÷ shares.
FCF yield 6.8% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 23.70 After-tax operating income per share (latest fiscal year).
Investment gains $93.29M Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income -$21.87M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 4.8% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $4.73B Revenue of the latest reported quarter.
Net income (qtr) $308.68M Net income of the latest reported quarter.
EPS (qtr) 5.22 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 5.3% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 2.1% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -10.9% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) -12.7% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -17.2% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) -13.9% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) 9.6% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 6.5% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $18.35B Revenue of the last four quarters.
Net income (TTM) $1.46B Net income of the last four quarters.
EPS (TTM) 23.86 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 8.0% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 13.5% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 6.3% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.4% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) $0.8000 Dividends per share paid over the last 12 months.
Payout ratio 3.5% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 6.0% Dividends ÷ free cash flow.
Dividend growth (1y) 0.0% Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) 0.0% Annualised dividend growth over 3 years.
Dividend CAGR (5y) 5.9% Annualised dividend growth over 5 years.
Payments (12m) 4 Number of dividend payments in the last 12 months.
Last ex-dividend date Sep 1, 2026 Most recent ex-dividend date.
Buyback yield 7.7% Share repurchases ÷ market cap.
Shareholder yield 8.1% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 15.0% EBITDA ÷ revenue.
Operating margin 11.5% Operating income ÷ revenue.
Net margin 8.6% Net income ÷ revenue.
FCF margin 4.9% Free cash flow ÷ revenue.
ROE 20.5% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 9.6% Return on assets: net income ÷ total assets.
ROIC 12.9% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 9.7% Latest fiscal year revenue vs the year before.
Net income growth (annual) 30.4% Latest fiscal year net income vs the year before.
EPS growth (annual) 37.3% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 9.0% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) 36.2% Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 1.05 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 1.05 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.04 Cash ÷ current liabilities.
Debt / equity 0.65 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.31 Total debt ÷ total assets.
Debt / EBITDA 1.82 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA 1.77 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage 12.78 Operating income ÷ interest expense.
Earnings quality
FCF conversion 57.0% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -2.4% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 0.6% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 23.4% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 1.12 Revenue ÷ total assets.
Days sales outstanding 55 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $246.33 Highest price in the last 52 weeks.
52-week low $138.06 Lowest price in the last 52 weeks.
From 52-week high -21.1% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 40.7% How far above the 52-week low the price is.
Avg volume (30d) 364.33K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $67.49M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 7 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 3.19 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $17.36B Revenue of the latest fiscal year.
Net income $1.49B Net income of the latest fiscal year.
Diluted EPS 23.10 Diluted earnings per share of the latest fiscal year.
EBITDA $2.61B Operating income + depreciation & amortization.
Free cash flow $849.25M Operating cash flow − capital spending.
Total debt $4.75B Long-term plus current debt.
Cash $137.80M Cash and equivalents.
Equity $7.28B Shareholders' equity.
Total assets $15.53B Total assets.